Literature DB >> 18084622

Expression of androgen receptor is negatively regulated by p53.

Fatouma Alimirah1, Ravichandran Panchanathan, Jianming Chen, Xiang Zhang, Shuk-Mei Ho, Divaker Choubey.   

Abstract

Increased expression of androgen receptor (AR) in prostate cancer (PC) is associated with transition to androgen independence. Because the progression of PC to advanced stages is often associated with the loss of p53 function, we tested whether the p53 could regulate the expression of AR gene. Here we report that p53 negatively regulates the expression of AR in prostate epithelial cells (PrECs). We found that in LNCaP human prostate cancer cells that express the wild-type p53 and AR and in human normal PrECs, the activation of p53 by genotoxic stress or by inhibition of p53 nuclear export downregulated the expression of AR. Furthermore, forced expression of p53 in LNCaP cells decreased the expression of AR. Conversely, knockdown of p53 expression in LNCaP cells increased the AR expression. Consistent with the negative regulation of AR expression by p53, the p53-null HCT116 cells expressed higher levels of AR compared with the isogenic HCT116 cells that express the wildtype p53. Moreover, we noted that in etoposide treated LNCaP cells p53 bound to the promoter region of the AR gene, which contains a potential p53 DNA-binding consensus sequence, in chromatin immunoprecipitation assays. Together, our observations provide support for the idea that the loss of p53 function in prostate cancer cells contributes to increased expression of AR.

Entities:  

Keywords:  DNA damage; Prostate cancer; androgen receptor; p53; transcriptional repression

Mesh:

Substances:

Year:  2007        PMID: 18084622      PMCID: PMC2134911          DOI: 10.1593/neo.07769

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  51 in total

1.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

Review 2.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

3.  Androgen suppressed apoptosis is modified in p53 deficient mice.

Authors:  M Colombel; F Radvanyi; M Blanche; C Abbou; R Buttyan; L A Donehower; D Chopin; J P Thiery
Journal:  Oncogene       Date:  1995-04-06       Impact factor: 9.867

4.  p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction.

Authors:  J L Shenk; C J Fisher; S Y Chen; X F Zhou; K Tillman; L Shemshedini
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

5.  Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines.

Authors:  Marcus V Cronauer; Wolfgang A Schulz; Tatjana Burchardt; Rolf Ackermann; Martin Burchardt
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

6.  Defining aggressive prostate cancer using a 12-gene model.

Authors:  Tarek A Bismar; Francesca Demichelis; Alberto Riva; Robert Kim; Sooryanarayana Varambally; Le He; Jeff Kutok; Jonathan C Aster; Jeffery Tang; Rainer Kuefer; Matthias D Hofer; Phillip G Febbo; Arul M Chinnaiyan; Mark A Rubin
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

7.  Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.

Authors:  Nancy J Nesslinger; Xu-Bao Shi; Ralph W deVere White
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

8.  Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: implications for cancer cell fate determination after genotoxic stress.

Authors:  Fatouma Alimirah; Ravichandran Panchanathan; Francesca J Davis; Jianming Chen; Divaker Choubey
Journal:  Neoplasia       Date:  2007-05       Impact factor: 5.715

9.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

10.  Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival.

Authors:  Qing Yang; Kar-Ming Fung; Wanda V Day; Bradley P Kropp; Hsueh-Kung Lin
Journal:  Cancer Cell Int       Date:  2005-04-06       Impact factor: 5.722

View more
  39 in total

Review 1.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

2.  Multivalent Peptoid Conjugates Which Overcome Enzalutamide Resistance in Prostate Cancer Cells.

Authors:  Yu Wang; Dilani C Dehigaspitiya; Paul M Levine; Adam A Profit; Michael Haugbro; Keren Imberg-Kazdan; Susan K Logan; Kent Kirshenbaum; Michael J Garabedian
Journal:  Cancer Res       Date:  2016-08-03       Impact factor: 12.701

3.  Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.

Authors:  Laura D Locati; Federica Perrone; Barbara Cortelazzi; Martina Imbimbo; Paolo Bossi; Paolo Potepan; Enrico Civelli; Gaetana Rinaldi; Pasquale Quattrone; Lisa Licitra; Silvana Pilotti
Journal:  Cancer Biol Ther       Date:  2014-03-11       Impact factor: 4.742

4.  ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.

Authors:  Daria Fleyshman; Peter Cheney; Anda Ströse; Shaila Mudambi; Alfiya Safina; Mairead Commane; Andrei Purmal; Kelsey Morgan; Nicholas J Wang; Joe Gray; Paul T Spellman; Natalia Issaeva; Katerina Gurova
Journal:  Cell Cycle       Date:  2015-12-22       Impact factor: 4.534

5.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

6.  Tumor suppressor protein p53 negatively regulates human pregnane X receptor activity.

Authors:  Ayesha Elias; Jing Wu; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2013-03-27       Impact factor: 4.436

7.  Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer.

Authors:  Xiang Zhang; Mengchu Wu; Hong Xiao; Ming-Tsung Lee; Linda Levin; Yuet-Kin Leung; Shuk-Mei Ho
Journal:  Prostate       Date:  2010-05-15       Impact factor: 4.104

8.  Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.

Authors:  Venkateshwar Madka; Altaf Mohammed; Qian Li; Yuting Zhang; Laura Biddick; Jagan M R Patlolla; Stan Lightfoot; Rheal A Towner; Xue-Ru Wu; Vernon E Steele; Levy Kopelovich; Chinthalapally V Rao
Journal:  Cancer Prev Res (Phila)       Date:  2015-11-17

9.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

10.  An androgen receptor-microrna-29a regulatory circuitry in mouse epididymis.

Authors:  Wubin Ma; Shuanggang Hu; Guangxin Yao; Shengsong Xie; Minjie Ni; Qiang Liu; Xinxing Gao; Jun Zhang; Xingxu Huang; Yonglian Zhang
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.